See more : Wynn Macau, Limited (WYNMY) Income Statement Analysis – Financial Results
Complete financial analysis of Sunho Biologics Inc (2898.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sunho Biologics Inc, a leading company in the industry within the sector.
You may be interested
- Nexity SA (NNXXY) Income Statement Analysis – Financial Results
- Voyager Therapeutics, Inc. (VYGR) Income Statement Analysis – Financial Results
- Yowie Group Limited (YWGRF) Income Statement Analysis – Financial Results
- Origin Bancorp, Inc. (OBNK) Income Statement Analysis – Financial Results
- Noble Corporation Plc (NBLTF) Income Statement Analysis – Financial Results
Sunho Biologics Inc (2898.HK)
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 208.00K | 1.73M | 3.22M |
| Cost of Revenue | 70.00K | 1.26M | 0.00 |
| Gross Profit | 138.00K | 473.00K | 3.22M |
| Gross Profit Ratio | 66.35% | 27.33% | 100.00% |
| Research & Development | 43.04M | 53.17M | 64.03M |
| General & Administrative | 40.70M | 5.56M | 5.80M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 40.70M | 5.56M | 5.80M |
| Other Expenses | 0.00 | 8.00K | 0.00 |
| Operating Expenses | 138.00K | 46.68M | 69.83M |
| Cost & Expenses | 83.74M | 47.94M | 69.83M |
| Interest Income | 3.47M | 15.00K | 0.00 |
| Interest Expense | 692.00K | 5.07M | 0.00 |
| Depreciation & Amortization | 8.64M | 8.81M | 2.40M |
| EBITDA | -123.37M | -38.11M | -64.21M |
| EBITDA Ratio | -59,312.02% | -2,157.65% | -1,996.70% |
| Operating Income | -71.08M | -46.16M | -66.62M |
| Operating Income Ratio | -34,171.63% | -2,666.49% | -2,071.39% |
| Total Other Income/Expenses | -61.62M | -5.78M | -4.02M |
| Income Before Tax | -132.70M | -51.99M | -70.63M |
| Income Before Tax Ratio | -63,798.56% | -3,003.35% | -2,196.27% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 |
| Net Income | -132.70M | -51.99M | -70.63M |
| Net Income Ratio | -63,798.56% | -3,003.35% | -2,196.27% |
| EPS | -1.43 | -0.57 | -0.78 |
| EPS Diluted | -1.43 | -0.57 | -0.78 |
| Weighted Avg Shares Out | 92.88M | 91.21M | 91.00M |
| Weighted Avg Shares Out (Dil) | 92.88M | 91.21M | 91.00M |
No news found for: 2898.HK
Source: https://incomestatements.info
Category: Stock Reports